Evaluation of cross-protection of African swine fever vaccine ASFV-G-ΔI177L between ASFV biotypes

Background/Objectives: Vaccine development for the prevention of ASF has been very challenging due to the extensive genetic and largely unknown antigenic diversity. Inactivated vaccines, using different inactivation methods and a variety of adjuvants, have been consistently inefficacious. Historical...

Full description

Bibliographic Details
Main Authors: Borca, M.V., Ramirez-Medina, E., Mutisya, Christine, Ojuok, Rose, Odaba, Josiah, Dihbol, M., Lacasta, Anna, Gladue, D.P.
Format: Journal Article
Language:Inglés
Published: MDPI 2025
Subjects:
Online Access:https://hdl.handle.net/10568/176106

Similar Items: Evaluation of cross-protection of African swine fever vaccine ASFV-G-ΔI177L between ASFV biotypes